Progression of optic neuritis to multiple sclerosis in the County of Split-Dalmatia, Croatia. 2007

Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
Department of Ophthalmology, University Hospital "Split", Split, Croatia. lovreb@kbsplit.hr

The aim of this study was to determine the incidence of monosymptomatic optic neuritis (MON) and progression of MON to multiple sclerosis (MS) from the Mediterranean region of southern Europe in the County of Split-Dalmatia, Croatia during the 11 years period from 1991 to 2001. This study was made retrospectively on the 87 cases (59 female, aged 25.9 +/- 11.3 and 28 male aged 29.9 +/- 9.2) of MON, which were treated at the Department of Ophthalmology and Department of Neurology, Split, University Hospital, from January 1991 to December 2001. In each case the diagnosis was confirmed by a chart review and cases were ascribed to the data of admittance at hospital. The annual incidence of MON was 1.9 per 100,000 (95% CI, 0.4-3.5). The incidence among males was 1.2 (95% CI, 0-2.9) cases / 100,000 per year and 2.5 (95% CI, 0.1-4.9) among females. A significant seasonal variations in the incidence of MON was not found (chi2 = 6.81, p = 0.08). MS developed in 20 of 87 patients (22.9%) and median time was 25 (SE 8) months, (95% CI, 9-41) after the MON onset. After two years 12.6% of patients with MON developed MS, 20.6% after 5 years and 22.9% after 10 years. MS was slightly but not significantly more frequent in women than in men (chi2 = 0.72, p = 0.3). In conclusion, the progression of MON to MS in the County of Split-Dalmatia, Croatia was at a relatively moderate frequency.

UI MeSH Term Description Entries
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009902 Optic Neuritis Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis). Neuropapillitis,Retrobulbar Neuritis,Anterior Optic Neuritis,Posterior Optic Neuritis,Anterior Optic Neuritides,Neuritides, Anterior Optic,Neuritides, Optic,Neuritides, Posterior Optic,Neuritides, Retrobulbar,Neuritis, Anterior Optic,Neuritis, Optic,Neuritis, Posterior Optic,Neuritis, Retrobulbar,Neuropapillitides,Optic Neuritides,Optic Neuritides, Anterior,Optic Neuritides, Posterior,Optic Neuritis, Anterior,Optic Neuritis, Posterior,Posterior Optic Neuritides,Retrobulbar Neuritides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D017523 Croatia Created 7 April 1992 as a result of the division of Yugoslavia.
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
April 2010, Clinical rheumatology,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
October 2007, Military medicine,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
January 1998, International ophthalmology,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
May 2009, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
July 2016, Joint bone spine,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
August 2018, Therapeutic drug monitoring,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
January 2000, European journal of epidemiology,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
December 2017, European journal of internal medicine,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
September 2009, Acta clinica Croatica,
Lovro Bojić, and Veljko Rogosić, and Milan Ivanisević, and Meri Matijaca, and Ivo Lusić, and Irena Pintarić, and Veselin Vrebalov-Cindro, and Goran Racić
January 1966, Acta neurologica Scandinavica,
Copied contents to your clipboard!